Homegrown drugmaker, PE firm among suitors for Samara Capital’s pharma platform
11 March, 2021
Photo Credit: Thinkstock
Samara Capital’s pharma platform has received interest from the country’s top drug maker and a homegrown private equity...
TO READ THE FULL STORY
The only platform exclusively covering Private Investments in India.
Exclusive reporting, expert analyses and commentary on PE/VC/M&A deals and dealmakers
Daily, weekly and monthly curated newsletters on the alternative investment ecosystem in India
Participation in VCCircle Marquee events at concessional rates
Latest VCCEdge annual, quarterly and industry reports
Comprehensive | Accurate | Unbiased | Impeccably sourced